-
-
-
-
-
-
-
TD Cowen Downgrades Cardiff Oncology (CRDF) to Hold
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Cardiff Oncology (CRDF)
-
-
-
-
-
-
-
Cardiff Oncology presents leukemia trial data at ASH 2025
-
-
-
-
-
-
-
Cardiff Oncology (CRDF) Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel
-
-
-
-
-
-
-
Cardiff Oncology (CRDF) Files Mixed Shelf
-
-
-
-
-
-
-
Cardiff Oncology, Inc. (CRDF) Misses Q2 EPS by 1c
481,612 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


